Matthew B Frieman Selected Research

Emulsions

5/2021

Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew B Frieman Research Topics

Disease

28	Infections 11/2023 - 01/2010
20	COVID-19 12/2023 - 01/2020
11	Virus Diseases (Viral Diseases) 01/2023 - 10/2010
4	Coronavirus Infections 05/2022 - 08/2014
4	Severe Acute Respiratory Syndrome 12/2017 - 01/2010
3	Human Influenza (Influenza) 11/2021 - 05/2015
3	Emerging Communicable Diseases (Emerging Infectious Diseases) 12/2017 - 02/2016
3	Lung Diseases (Lung Disease) 01/2017 - 02/2014
2	Insulin Resistance 11/2023 - 12/2022
2	Metabolic Diseases (Metabolic Disease) 11/2023 - 12/2022
2	Obesity 11/2023 - 12/2022
2	Neoplasms (Cancer) 12/2017 - 08/2014
2	Fibrosis (Cirrhosis) 01/2017 - 01/2017
2	Inflammation (Inflammations) 04/2015 - 04/2010
1	Atherosclerosis 01/2023
1	Reinfection 12/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2022
1	Alzheimer Disease (Alzheimer's Disease) 09/2022
1	Necrosis 01/2022
1	Vesicular Stomatitis 01/2022
1	Bites and Stings (Sting) 05/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2021
1	Rabies (Hydrophobia) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Lung Injury 01/2017
1	Pneumococcal Infections 05/2015
1	Arthritis (Polyarthritis) 04/2015
1	Hepatitis 08/2014

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 11/2023 - 01/2017
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2010
10	Antiviral Agents (Antivirals)IBA 12/2022 - 04/2014
6	Messenger RNA (mRNA)IBA 11/2023 - 11/2010
6	InterferonsIBA 10/2023 - 10/2010
4	mRNA VaccinesIBA 11/2023 - 01/2022
4	Neutralizing AntibodiesIBA 01/2022 - 07/2015
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2023 - 02/2014
3	remdesivirIBA 12/2022 - 06/2021
3	NucleosidesIBA 12/2022 - 06/2021
3	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2011
3	CytokinesIBA 09/2022 - 01/2012
3	AntibodiesIBA 01/2022 - 07/2015
3	Viral RNAIBA 11/2021 - 09/2020
3	Phosphotransferases (Kinase)IBA 01/2018 - 02/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 12/2022 - 10/2021
2	pyrimidineIBA 01/2022 - 06/2021
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2021 - 12/2020
2	Carrier Proteins (Binding Protein)IBA 09/2020 - 05/2015
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 10/2016
2	Antipsychotic Agents (Antipsychotics)IBA 12/2017 - 08/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
2	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 11/2010 - 10/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	Cyclic NucleotidesIBA 06/2023
1	SARS-CoV-2 ORF6 proteinIBA 01/2023
1	Immunoglobulin A (IgA)IBA 12/2022
1	nirmatrelvir and ritonavir drug combinationIBA 12/2022
1	apilimodIBA 12/2022
1	Neuropilin-1IBA 09/2022
1	Viral AntigensIBA 01/2022
1	FibrinIBA 01/2022
1	molnupiravirIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	EmulsionsIBA 05/2021
1	Pattern Recognition ReceptorsIBA 05/2021
1	Aluminum Hydroxide (Algeldrate)FDA Link 05/2021
1	Peptide Hydrolases (Proteases)FDA Link 02/2021
1	AntigensIBA 01/2021
1	Matrix-MIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 12/2020
1	Nucleic AcidsIBA 09/2020
1	Antisense OligonucleotidesIBA 01/2020
1	PhosphoproteinsIBA 01/2020
1	Sulfhydryl Compounds (Thiols)IBA 01/2020
1	GoldIBA 01/2020
1	Sirtuin 1IBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 12/2017
1	AmphiregulinIBA 01/2017
1	LigandsIBA 01/2017
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017
1	NanovaccinesIBA 01/2017
1	hippuryl-glycyl-glycine (HIGG)IBA 02/2016
1	Polysaccharides (Glycans)IBA 05/2015
1	Neuraminidase (Sialidase)IBA 05/2015
1	LectinsIBA 05/2015
1	Galectin 3 (LGALS3)IBA 05/2015
1	Galectin 1 (LGALS1)IBA 05/2015
1	CarbohydratesIBA 05/2015
1	Galectins (Galectin)IBA 05/2015
1	celastrolIBA 04/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2015
1	Mitogen-Activated Protein KinasesIBA 02/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2015
1	TOR Serine-Threonine KinasesIBA 02/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2014
1	SSYA10-001IBA 08/2014

Therapy/Procedure

5	Therapeutics 10/2020 - 04/2015
1	Off-Label Use 10/2020